Literature DB >> 8432143

Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.

Y Honda1, H Takahashi, N Shijubo, Y Kuroki, T Akino.   

Abstract

Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of large quantities of lipoproteinaceous materials in alveoli. Surfactant protein A (SP-A) is the predominant phospholipid-associated glycoprotein in pulmonary surfactant and is specific to the lung. The contents of SP-A in bronchoalveolar lavage (BAL) fluids of patients with PAP were measured with an enzyme-linked immunosorbent assay using two monoclonal antibodies to human SP-A to evaluate its usefulness for diagnosis. Concentration of SP-A in BAL fluid in PAP was significantly increased in comparison with that of normal volunteers. The ratio of SP-A to protein in BAL fluid of PAP was at almost the same level as in normal subjects, while the ratio of SP-A to phospholipid in PAP was significantly higher. These results indicate that measurement of BAL fluid SP-A is of clinical value for diagnosis of PAP and should be used as a biochemical diagnostic tool in the clinical laboratory.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432143     DOI: 10.1378/chest.103.2.496

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Stretch increases alveolar epithelial permeability to uncharged micromolecules.

Authors:  Kenneth J Cavanaugh; Taylor S Cohen; Susan S Margulies
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-09       Impact factor: 4.249

3.  Bronchoalveolar lavage with trypsin in pulmonary alveolar proteinosis.

Authors:  Y Nagasaka; M Takahashi; H Ueshima; Y Tohda; S Nakajima
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

Review 4.  Surfactant protein-A: new insights into an old protein--Part I.

Authors:  A R Kumar; J M Snyder
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

Review 5.  Surfactant protein-A: new insights into an old protein--II.

Authors:  A R Kumar; J M Snyder
Journal:  Indian J Pediatr       Date:  1998 Nov-Dec       Impact factor: 1.967

6.  Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans.

Authors:  A M Karinch; D E deMello; J Floros
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

7.  Long-term effects of instilled mineral dusts on pulmonary surfactant isolated from monkeys.

Authors:  C L Schengrund; X Chi; J Sabol; J W Griffith
Journal:  Lung       Date:  1995       Impact factor: 2.584

Review 8.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 9.  Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury.

Authors:  Patricia Silveyra; Joanna Floros
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  Roflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type II.

Authors:  Kerstin Höhne; Stephan J Schliessmann; Andreas Kirschbaum; Till Plönes; Joachim Müller-Quernheim; Hermann Tenor; Gernot Zissel
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.